Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Intranasal Ketamine for Pediatric Procedural Sedation: a Feasibility Study


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT03067974

Organisation Name: University of Arizona

Overal Status: Terminated

Start Date: September 21, 2017

Last Update: January 28, 2019

Lead Sponsor: University of Arizona

Brief Summary: The purpose of this study is to evaluate the feasibility of intranasal ketamine for adequate sedation of children undergoing minor procedures in the Emergency Department. An intranasal dose of 10mg/kg will be used in patients requiring procedural sedation. The investigators hypothesize that this dose of intranasal ketamine will be able to provide adequate sedation and analgesia for the physician to successfully complete the planned diagnostic or therapeutic intervention (Pediatr Emer Care 2012;28: 767-70). The primary endpoint will be successful sedation, as defined by the ability to complete the planned procedure without rescue medication, which includes re-dosing of the same medication.

Conditions:
  • Failed Moderate Sedation During Procedure
  • Ketamine Adverse Reaction


Total execution time in seconds: 0.14569497108459